JCPRX
Price
$25.64
Change
-$0.23 (-0.89%)
Updated
Jul 13 closing price
Net Assets
3.7B
VSMPX
Price
$337.67
Change
-$2.70 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

JCPRX vs VSMPX

JCPRX vs VSMPX Comparison Chart in %
View a ticker or compare two or three
VS
JCPRX vs. VSMPX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JCPRX is a Buy and VSMPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMPX has more cash in the bank: 2.3T vs. JCPRX (3.7B). VSMPX pays higher dividends than JCPRX: VSMPX (1.06) vs JCPRX (0.13). JCPRX was incepted earlier than VSMPX: JCPRX (20 years) vs VSMPX (11 years). JCPRX (1.54) is less costly to investors than VSMPX (0.02). JCPRX is a more actively managed with annual turnover of: 100.00 vs. VSMPX (3.00). JCPRX has a lower initial minimum investment than VSMPX: JCPRX (0) vs VSMPX (100000000). VSMPX annual gain was more profitable for investors over the last year : 21.48 vs. JCPRX (13.14). VSMPX return over 5 years is better than : 66.52 vs. JCPRX (-8.50).
JCPRXVSMPXJCPRX / VSMPX
Total Expense Ratio1.440.027,200%
Annual Report Gross Expense Ratio1.540.027,700%
Fund Existence20 years11 years-
Gain YTD7.92711.20671%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.7B2.3T0%
Annual Yield % from dividends0.131.0612%
Returns for 1 year13.1421.4861%
Returns for 3 years42.4567.0363%
Returns for 5 years-8.5066.52-13%
Returns for 10 years-3.45239.43-1%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VGSNX21.35N/A
N/A
Vanguard Real Estate Index Institutional
PCAOX91.03N/A
N/A
Principal Capital Appreciation R3
GARIX23.88N/A
N/A
Gotham Absolute Return Institutional
RLAIX24.27N/A
N/A
T. Rowe Price Latin America I
MCYCX15.72-0.49
-3.02%
NYLI Candriam Emerging Markets Eq Cl C